Vetmedin 1,25 mg Kautabletten für Hunde
Vetmedin 1,25 mg Kautabletten für Hunde
Authorised
- Pimobendan
Product identification
Medicine name:
Vetmedin 1,25 mg Kautabletten für Hunde
Vetmedin 1,25 mg kauwtabletten voor honden
Active substance:
- Pimobendan
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pimobendan1.25milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- Cardboard box containing 100 tablets in a polyethylene bottle, closed with a polypropylene child-resistant screw cap
- Cardboard box containing 50 tablets in a polyethylene bottle, closed with a polypropylene child-resistant screw cap
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 112234
Date of authorisation status change:
Reference member state:
-
Austria
Procedure number:
- AT/V/0006/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 15/12/2023
Dutch (PDF)
Published on: 18/01/2022
How useful was this page?: